Leptin to Treat Lipodystrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Lipodystrophy
Interventions
DRUG

Metreleptin

Drug treatment

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00025883 - Leptin to Treat Lipodystrophy | Biotech Hunter | Biotech Hunter